Literature DB >> 14977516

The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma.

Kazuyuki Hirooka1, Masaaki Tokuda, Osamu Miyamoto, Toshifumi Itano, Tetsuya Baba, Fumio Shiraga.   

Abstract

PURPOSE: To investigate the effect of Ginkgo biloba extract (EGb 761) against neurotoxicity of retinal ganglion cells of rats with chronic moderately elevated intraocular pressure (IOP).
METHODS: Unilateral chronic moderately elevated IOP was produced in rats by cautery of three episcleral vessels. Secondary degeneration was measured with and without EGb 761 for 5 months. At 5 months, retinal ganglion cells were labeled with a fast blue tracer applied to both superior colliculi. Densities of surviving retinal ganglion cells were estimated by counting fast blue labeled cells in whole mounted retinas.
RESULTS: When compared with their contralateral control eyes with normal IOP, in the peripheral retina, retinal ganglion cell loss in eyes with chronic, moderately elevated IOP was 29.8 +/- 1.5% (n=5) at 5 months in untreated animals and 4.6 +/- 4.5% (n=5) at 5 months in treated animals with EGb 761.
CONCLUSIONS: Pretreatment and early posttreatment with EGb 761 is an effective neuroprotectant in a rat model of chronic glaucoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977516     DOI: 10.1076/ceyr.28.3.153.26246

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  20 in total

1.  Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma.

Authors:  Seong Hee Shim; Joon Mo Kim; Chul Young Choi; Chan Yun Kim; Ki Ho Park
Journal:  J Med Food       Date:  2012-08-07       Impact factor: 2.786

Review 2.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

3.  [Primary open-angle glaucoma and systemic diseases].

Authors:  M Pache
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

Review 4.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

Review 6.  [Vasculat treatment concepts in glaucoma patients].

Authors:  Karin R Pillunat; Lutz E Pillunat
Journal:  Ophthalmologe       Date:  2021-05       Impact factor: 1.059

7.  The association between self-reported glaucoma and ginkgo biloba use.

Authors:  Rita Khoury; Jennifer Moren Cross; Christopher A Girkin; Cynthia Owsley; Gerald McGwin
Journal:  J Glaucoma       Date:  2009-09       Impact factor: 2.503

Review 8.  Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma.

Authors:  A K Cybulska-Heinrich; M Mozaffarieh; J Flammer
Journal:  Mol Vis       Date:  2012-02-09       Impact factor: 2.367

Review 9.  Neuroprotective therapies for glaucoma.

Authors:  Wei Song; Ping Huang; Chun Zhang
Journal:  Drug Des Devel Ther       Date:  2015-03-11       Impact factor: 4.162

10.  α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction.

Authors:  Denise M Inman; Wendi S Lambert; David J Calkins; Philip J Horner
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.